tiprankstipranks
Trending News
More News >
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market

Universe Pharmaceuticals (UPC) Income Statement

Compare
211 Followers

Universe Pharmaceuticals Income Statement

Last quarter (Q2 2025), Universe Pharmaceuticals's total revenue was $9.15M, a decrease of -50.44% from the same quarter last year. In Q2, Universe Pharmaceuticals's net income was $-3.28M. See Universe Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 23.02M$ 32.31M$ 40.14M$ 47.98M$ 30.70M
Gross Profit
$ 6.07M$ 10.32M$ 21.89M$ 25.33M$ 14.09M
Operating Expenses
$ 14.09M$ 13.84M$ 28.91M$ 11.74M$ 3.74M
Depreciation and Amortization
$ 485.73K$ 508.79K$ 533.95K$ 446.88K$ 410.08K
EBITDA
$ -7.36M$ -3.18M$ -6.40M$ 14.20M$ 10.61M
Operating Income
$ -8.02M$ -3.53M$ -7.02M$ 13.59M$ 10.25M
Other Income/Expenses
$ -100.75K$ -413.77K$ -545.35K$ 57.51K$ -151.29K
Pretax Income
$ -8.12M$ -3.94M$ -7.98M$ 13.65M$ 10.10M
Net Income
$ -8.73M$ -6.16M$ -8.74M$ 11.32M$ 7.56M
Per Share Metrics
Basic EPS
$ -1.44K$ -1.04K$ -1.48K$ 2.15K$ 1.30K
Diluted EPS
$ -1.44K$ -1.04K$ -1.48K$ 2.15K$ 1.30K
Weighted Average Shares Outstanding
6.08K 5.92K 5.92K 5.27K 5.83K
Weighted Average Shares Outstanding (Diluted)
6.08K 5.92K 5.92K 5.27K 5.83K
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History